Optimer Pharmaceuticals (OPTR) Reports Q1 EPS of $1.04, Up $1.43 Y/Y
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Consolidated net income (loss): -26.87M
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Consolidated net income (loss): -26.87M
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q1 EPS of $1.04, versus ($0.39) last year. Revenue for the quarter came in at $69.28 million, versus $297.44 thousand last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance
- Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
